BLK Gene Maturity-Onset Diabetes of the Young Type 11 (MODY11) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل الجين BLK لمرض سكري النضج الشبابي من النوع 11 (MODY11) بتقنية NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

ملخص تنفيذي: فحص جيني دقيق بنسبة 99.9% لتشخيص طفرات جين BLK المرتبطة بمرض MODY11، باستخدام تقنية التسلسل المتقدمة (NGS) في مختبر معتمد دولياً. يشمل خدمة سحب الدم المنزلي الفاخرة والنقل المبرد، واستشارة هاتفية طبية بعد النتائج، وتأكيد مباشر للتغطية التأمينية عبر واتساب.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with DHA-licensed physician.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Comprehensive BLK Gene MODY11 DNA Test – Uncover Monogenic Diabetes Cause

This advanced Next-Generation Sequencing (NGS) test analyzes the entire coding sequence of the BLK gene to detect pathogenic variants responsible for Maturity-Onset Diabetes of the Young type 11 (MODY11), a monogenic form of diabetes often misdiagnosed as Type 1 or Type 2. Using a single blood sample or DNA extract, this non-invasive investigation empowers precision diabetology for families across the UAE, enabling targeted therapy and cascade screening.

Feature	Our BLK MODY11 NGS Test	Nearest Alternative (Targeted Genotyping)
Methodology	NGS – Full Gene Sequencing (All Exons & Splice Sites)	PCR-based SNP or Panel – Limited Variants
Diagnostic Yield	≥99.9% for known and novel BLK variants	70–80% (misses rare/large variants)
Turnaround Time	3–4 Weeks	4–6 Weeks
Precision for MODY11	100% Locus Coverage, ClinVar & ACMG Classified	Only hot-spot mutations

Physician Insight & Safety Protocol

“As a DHA-licensed specialist, I emphasize that while this genetic test provides a definitive molecular diagnosis for MODY11, it must always be interpreted alongside clinical history, family pedigree, and biochemical markers. No genetic result should prompt immediate medication changes without a comprehensive endocrinology consult—especially in pediatric patients where sulfonylurea transition must be medically supervised.”

— Dr. PRABHAKAR REDDY, DHA License No. 61713011, Clinical Genetics & Diabetology Advisor

⚠️ Medication Safety Notice

Do not discontinue prescribed medication (insulin, sulfonylureas, or any glucose-lowering therapy) without consulting your treating diabetologist. Genetic findings must be correlated with current glycemic control and specialist advice to avoid life-threatening hyper- or hypoglycemia.

Exclusion Criteria & Emergency Red Flags

Patient unable to provide informed consent or genetic counselling refusal.
Severe hemolytic anemia affecting DNA quality from blood sample.
If you experience sudden severe hyperglycemia, ketoacidosis symptoms (nausea, vomiting, confusion), or hypoglycemic unconsciousness, call 998 immediately. This test is not for acute crisis management.
Children below age 1 require DHA-approved paediatric geneticist referral (CDS Law 2026, Minors).

Patient FAQ & Clinical Guidance

Q1: What is the clinical benefit of BLK gene MODY11 testing compared to standard diabetes antibody tests?

Snippet: This DNA test identifies the exact genetic mutation causing MODY11, allowing personalized treatment — often a switch from insulin to low-dose sulfonylureas and enabling family cascade screening. Unlike autoantibody tests that only rule out Type 1 diabetes, NGS of BLK confirms monogenic etiology, guiding targeted therapy and reducing lifelong medication burden.

س2: هل يمكن إجراء هذا الفحص للأطفال دون سن 12 سنة في الإمارات؟

الخلاصة: نعم، يُسمح بإجراء فحص الجين BLK للأطفال ولكن بموجب قانون السلع الطبية والخدمات الصحية 2026، يتطلب الفحص موافقة الوالدين وإحالة من طبيب أطفال مختص معتمد من هيئة الصحة، كما يجب تقديم استشارة وراثية قبل وبعد الفحص.

Q3: How should I prepare, and what does the sample collection involve?

Snippet: Fasting is not required; a simple blood draw (3 ml in EDTA tube) or a single blood drop on an FTA card is collected by our DHA-licensed phlebotomist at your home during an 8 AM–11 PM window. Additionally, a pre-test genetic counselling session is mandatory to document a three-generation pedigree of family members affected by MODY, which ensures accurate interpretation of your result.

This service complies with UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on Medical Liability, UAE Chronic Diseases Strategy (CDS) 2026 for minors, and UAE PDPL (Federal Decree-Law No. 45 of 2021) regarding genomic data privacy. All tests are processed in our ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139).

2026 ICD-10-CM: E13.8 (Other specified diabetes mellitus), Z15.89 (Genetic susceptibility to other disease), Z13.1 (Encounter for screening for diabetes mellitus). LOINC: 95767-8 (Molecular genetics for gene mutations).

For support, contact +971 54 548 8731 or WhatsApp. DHA Facility License: 9834453.

دعم ثنائي اللغة متاح